INHALE (@HAP_Diagnostics) header
INHALE (@HAP_Diagnostics) profile picture

NIHR-funded research programme evaluating the use of rapid molecular diagnostics for HAP/VAP in Critical Care. https://nitter.gq/t.co/3tMP0IqQRp

London
Joined December 2016
Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)Photo by INHALE (@HAP_Diagnostics)
INHALE WP3 RCT health economic analysis now published in Critical Care. The Pneumonia Panel PCR had lower average ICU costs and was cost effective for antimicrobial stewardship, but not clinical cure. Read in full at: rdcu.be/eAmSD
2
4
157
'INHALE Poem II – A slight diversion’ shares the journey of INHALE, describing its hopes, challenges and implications of the research. This poem was written and performed by Amander Wellings, of the INHALE Patient, Carer and Public Involvement (PPI) group youtu.be/-UUBzbSmEo0?feature…
1
133
What is the impact of seeking pathogens by rapid molecular diagnostic methods on antibiotic stewardship and the clinical outcomes in hospital-acquired and ventilator-associated pneumonia? Visual abstract below and full paper available online at rdcu.be/ehlAu
1
2
75
INHALE compared rapid testing with standard care used to diagnose pneumonia in intensive care. Rapid testing gave faster results than standard care and improvements in antibiotic use. But, the machine did not improve cure of pneumonia, so more research is needed to understand why
2
3
133
1/4 Rapid molecular diagnostic tests for pathogens and resistance genes may improve antibiotic prescribing decisions and stewardship. However, clinicians’ desire to protect their patient with an antibiotic often overrides more distal concerns about possible resistance selection,
1
2
3
157
3/4 Implementation strategies for technological solutions to antimicrobial resistance must be ‘behaviourally intelligent’, recognising the challenges facing clinicians when making ‘life or death’ prescribing decisions.
1
35
1/2 The INHALE WP3 randomised trial provides multi-centre evidence that rapid syndromic PCR, delivered at the point-of care in the ICU improved antibiotic stewardship by 21% in absolute terms. Equivalence of clinical cure was not demonstrated. link.springer.com/article/10…
1
4
1
7
836
We’re expanding our reach! Follow us on: Bluesky: @ Inhale-Trial.bsky.social LinkedIn: INHALE trial (linkedin.com/company/inhale-…) For all of the latest news from INHALE.
1
1
71
Flexible job opportunity! We're seeking a research associate to work on the @HAP_Diagnostics project. Mainly analyses & data collection. Ideal candidate would have knowledge of microbiology and antimicrobials. Would suit recent graduate or similar. vacancies.uea.ac.uk/vacancie…
1
4
1
515
Great to be in sunny (but very windy) Cascais for #EHPS2024. Looking forward to presenting some of our work from @HAP_Diagnostics on Thursday!! ☀️
2
10
658
Our latest paper - exploring clinician prescribing behaviour in icu during the covid pandemic. – at Tottenham, London
2
145
Excited to share our latest paper from the INHALE research programme @HAP_Diagnostics exploring prescribers' attitudes towards using rapid molecular diagnostic technology to guide antibiotic prescribing in ICU patients with pneumonias - open access link: academic.oup.com/jac/advance…
2
4
443
Fascinating results from Dagfunn Markussen demonstrating that “high quality” and “low quality” respiratory samples showed no difference in detection of common pneumonia pathogens in CAP patients. #eccmid2023 – at Copenhagen, Denmark
1
2
337
Don’t miss INHALE RCT trial results of POCT multiplex pneumonia PCR presented by @Beat_AMR_Bugs today at 16:15 in Hall P. #ECCMID2023 – at Copenhagen, Denmark
4
4
408
Don’t miss INHALE RCT trial results of POCT multiplex pneumonia PCR presented by @Beat_AMR_Bugs today at 16:15 in Hall P. #ECCMID2023 – at Copenhagen, Denmark
4
4
408
Rob Horne: One major finding of our behaviour work was that clinicians do not sufficiently consider the immediate harms of broad-spectrum antibiotics. Future antibiotic stewardship interventions should focus on this. #eccmid2023
1
5
616
80% of clinicians believed molecular diagnostics but concerns such as fears of patient deterioration drove non-adherence to both the trial prescribing algorithm and hospital guidelines.
2
3
312
Our #healthec analysis shows ICU costs for participants in PCR intervention arm were lower in all scenarios analysed, Those in the @BioFireDX Pneumonia Panel arm had an average saving of £9,940 for the ICU stay. – at Copenhagen, Denmark
We’re presenting our alongside trial health economics and behaviour work today! Come and see us in sector C row 7 : P1701 and P1710 @DrSJStewart @NorwichCTU @Beat_AMR_Bugs
1
6
371